BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 17452531)

  • 21. Methods to Probe Conformational Activation and Mitochondrial Activity of Proapoptotic BAK.
    Singh G; Moldoveanu T
    Methods Mol Biol; 2019; 1877():185-200. PubMed ID: 30536007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction.
    Germain M; Milburn J; Duronio V
    J Biol Chem; 2008 Mar; 283(10):6384-92. PubMed ID: 18089567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis.
    Clohessy JG; Zhuang J; de Boer J; Gil-Gómez G; Brady HJ
    J Biol Chem; 2006 Mar; 281(9):5750-9. PubMed ID: 16380381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.
    Gillissen B; Essmann F; Hemmati PG; Richter A; Richter A; Oztop I; Chinnadurai G; Dörken B; Daniel PT
    J Cell Biol; 2007 Nov; 179(4):701-15. PubMed ID: 18025305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
    Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
    Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity.
    Wilson-Annan J; O'Reilly LA; Crawford SA; Hausmann G; Beaumont JG; Parma LP; Chen L; Lackmann M; Lithgow T; Hinds MG; Day CL; Adams JM; Huang DC
    J Cell Biol; 2003 Sep; 162(5):877-87. PubMed ID: 12952938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
    Letai A; Bassik MC; Walensky LD; Sorcinelli MD; Weiler S; Korsmeyer SJ
    Cancer Cell; 2002 Sep; 2(3):183-92. PubMed ID: 12242151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization.
    Yamaguchi R; Lartigue L; Perkins G; Scott RT; Dixit A; Kushnareva Y; Kuwana T; Ellisman MH; Newmeyer DD
    Mol Cell; 2008 Aug; 31(4):557-569. PubMed ID: 18691924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.
    Arnoult D; Bartle LM; Skaletskaya A; Poncet D; Zamzami N; Park PU; Sharpe J; Youle RJ; Goldmacher VS
    Proc Natl Acad Sci U S A; 2004 May; 101(21):7988-93. PubMed ID: 15148411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutual regulation of Bcl-2 proteins independent of the BH3 domain as shown by the BH3-lacking protein Bcl-x(AK).
    Plötz M; Hossini AM; Gillissen B; Daniel PT; Stockfleth E; Eberle J
    PLoS One; 2012; 7(4):e34549. PubMed ID: 22506026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak.
    Lindqvist LM; Heinlein M; Huang DC; Vaux DL
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8512-7. PubMed ID: 24912196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL-2-family protein tBID can act as a BAX-like effector of apoptosis.
    Flores-Romero H; Hohorst L; John M; Albert MC; King LE; Beckmann L; Szabo T; Hertlein V; Luo X; Villunger A; Frenzel LP; Kashkar H; Garcia-Saez AJ
    EMBO J; 2022 Dec; 41(2):e108690. PubMed ID: 34931711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues.
    Droga-Mazovec G; Bojic L; Petelin A; Ivanova S; Romih R; Repnik U; Salvesen GS; Stoka V; Turk V; Turk B
    J Biol Chem; 2008 Jul; 283(27):19140-50. PubMed ID: 18469004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL-2 proteins and apoptosis: Recent insights and unknowns.
    Edlich F
    Biochem Biophys Res Commun; 2018 May; 500(1):26-34. PubMed ID: 28676391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MOMP in the absence of BH3-only proteins.
    García Sáez AJ; Villunger A
    Genes Dev; 2016 Apr; 30(8):878-80. PubMed ID: 27083995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Bop is a novel BH3-only member of the Bcl-2 protein family.
    Zhang X; Weng C; Li Y; Wang X; Jiang C; Li X; Xu Y; Chen Q; Pan L; Tang H
    Protein Cell; 2012 Oct; 3(10):790-801. PubMed ID: 23055042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial membrane permeabilisation by Bax/Bak.
    Degli Esposti M; Dive C
    Biochem Biophys Res Commun; 2003 May; 304(3):455-61. PubMed ID: 12729579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.